Elastin- and collagen-rich human carotid plaques have increased levels of the cysteine protease inhibitor cystatin C

Journal of Vascular Research

Volumn 45, Issue 5, 2008, Pages 395-401

  Gonçalves, Isabel ^a,b   Ares, Mikko P S ^a   Moberg, Anna ^a   Moses, Jonatan ^a   To, Fong ^a   Montan, Jonathan ^a   Pedro, Luís M ^d   Dias, Nuno ^d   Fernandes E Fernandes, José ^d   Fredrikson, Gunilla Nordin ^a   Nilsson, Jan ^a   Jovinge, Stefan ^b,c   Bengtsson, Eva ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Higher School of Health Technologies of Lisbon   (Portugal)

Author keywords

Atherosclerosis; Cathepsin; Collagen; Cystatin C; Elastin

Indexed keywords

COLLAGEN; CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR; ELASTIN; GLYCOSAMINOGLYCAN; HYDROXYAPATITE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CYSTATIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CIGARETTE SMOKING; COLORIMETRY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; WESTERN BLOTTING; CAROTID ARTERY; CHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; BLOTTING, WESTERN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; COLLAGEN; COLORIMETRY; CYSTATINS; ELASTIN; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED;

EID: 50349083364     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121474     Document Type: Article

References (24)

1. Libby P, Lee RT: Matrix matters. Circulation 2000;102:1874-1876.
2. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005;85:1-31.
3. Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP: Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:1359-1366.
4. Chapman HA, Riese RJ, Shi GP: Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 1997;59:63-88.
5. Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, Weiss SJ: Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 2000;192:789-799.
6. Reddy VY, Zhang QY, Weiss SJ: Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA 1995;92:3849-3853.
7. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583.
8. Jormsjö S, Wuttge DM, Sirsjö A, Whatling C, Hamsten A, Stemme S, Eriksson P: Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2002;161:939-945.
9. Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, Frederik P, van der Made I, Daugherty A, Sijbers AM, Fisher A, Long CJ, Saftig P, Black D, Daemen MJ, Cleutjens KB: Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 2006;113:98-107.
10. Rodgers KJ, Watkins DJ, Miller AL, Chan PY, Karanam S, Brissette WH, Long CJ, Jackson CL: Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006;26:851-856.
11. Sukhova GK, Zhang Y, Pan JH, Wada Y, Yamamoto T, Naito M, Kodama T, Tsimikas S, Witztum JL, Lu ML, Sakara Y, Chin MT, Libby P, Shi GP: Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 2003;111:897-906.
12. Shi GP, Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, Ridker PM, Libby P, Chapman HA: Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999;104:1191-1197.
13. Bengtsson E, To F, Håkansson K, Grubb A, Brånen L, Nilsson J, Jovinge S: Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005;25:2151-2156.
14. Sukhova GK, Wang B, Libby P, Pan JH, Zhang Y, Grubb A, Fang K, Chapman HA, Shi GP: Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 2005;96:368-375.
15. Eriksson P, Deguchi H, Samnegård A, Lundman P, Boquist S, Tornvall P, Ericsson CG, Bergstrand L, Hansson LO, Ye S, Hamsten A: Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease. Arterioscler Thromb Vasc Biol 2004;24:551-557.
16. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379-1387.
17. Goncalves I, Moses J, Pedro LM, Dias N, Fernandes e Fernandes J, Nilsson J, Ares MP: Echolucency of carotid plaques correlates with plaque cellularity. Eur J Vasc Endovasc Surg 2003;26:32-38.
18. Goncalves I, Moses J, Dias N, Pedro LM, Fernandes e Fernandes J, Nilsson J, Ares MP: Changes related to age and cerebrovascular symptoms in the extracellular matrix of human carotid plaques. Stroke 2003;34:616-622.
19. Reddy GK, Enwemeka CS: A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996;29:225-229.
20. Thomas GJ, Davies M: The potential role of human kidney cortex cysteine proteinases in glomerular basement membrane degradation. Biochim Biophys Acta 1989;990:246-253.
21. Svensson L, Oldberg Å, Heinegård D: Collagen binding proteins. Osteoarthritis Cartilage 2001;9(suppl A):S23-S28.
22. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001;21:1998-2003.
23. Yamashita DS, Dodds RA: Cathepsin K and the design of inhibitors of cathepsin K. Curr Pharm Des 2000;6:1-24.
24. Krettek A, Sukhova GK, Libby P: Elastogenesis in human arterial disease: a role for macrophages in disordered elastin synthesis. Arterioscler Thromb Vasc Biol 2003;23:582-587.